Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) EPS (Basic) (2016 - 2021)

Nu-Med Plus' EPS (Basic) history spans 10 years, with the latest figure at -$0.0 for Q3 2021.

  • Quarterly results put EPS (Basic) at -$0.0 for Q3 2021, up 85.08% from a year ago — trailing twelve months through Sep 2021 was -$0.01 (up 66.67% YoY), and the annual figure for FY2021 was -$0.01, up 75.0%.
  • EPS (Basic) for Q3 2021 was -$0.0 at Nu-Med Plus, up from -$0.0 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.11 in Q1 2017 to a low of -$0.02 in Q2 2020.
  • The 5-year median for EPS (Basic) is -$0.0 (2018), against an average of $0.01.
  • The sharpest move saw EPS (Basic) soared 1141.35% in 2017, then crashed 263.67% in 2020.
  • Year by year, EPS (Basic) stood at $0.1 in 2017, then crashed by 109.6% to -$0.01 in 2018, then soared by 53.92% to -$0.0 in 2019, then tumbled by 117.01% to -$0.01 in 2020, then skyrocketed by 85.08% to -$0.0 in 2021.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.0, -$0.0, and -$0.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.